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A mass spectrometry-based method that does not involve the use of radioIabeling was 
developed for selective detection of phosphopeptides in complex mixtures. Mixtures of 
phosphorylated and nonphosphorylated peptides at the low picomole level are analyzed by 
negative ion electros ray liquid chromatography/mass spectrometry using C-18 packed 
fused-silica columns P <320-pm i-d.). Peptides and phosphopeptides in the chromatographic 
eluant undergo collision-induced dissociation in the free-jet expansion region prior to the 
mass analyzing quadrupole. Using relatively high collisional excitation potentials, phospho 
peptides containing phosphoserine, phosphothreonine, and phosphotyrosine fragment to 
yield diagnostic ions at m/z 63 and 79 corresponding to PO; and PO;, respectively. 
Chromatographic peaks containing phosphopeptides are indicated where these diagnostic 
ions maximize. The highest sensitivity for phosphopeptide detection is obtained using 
selected-ion monitoring for m/z 63 and 79. Full-scan mass spectra that exhibit the diagnostic 
phosphopeptide fragment ions, together with pseudomolecular ions, may be obtained by 
stepping the collisional excitation potential from a high value during the portion of each scan 
in which the low-mass-to-charge ratio diagnostic marker ions are being detected to a lower 
value while the upper mass-to-charge ratio range is being scanned. Good sensitivity for 
phosphopeptide detection was achieved using standard trifluoroacetic acid containing mo- 
bile phases for reversed-phase high-performance liquid chromatography. Data illustrating 
the selectivity and sensitivity of the approach are presented for mixtures of peptides and 
phosphopeptides containing the three commonly phosphorylated amino acids. fJ Am Sot 
Mass Spectrom 2993, 4, 710-717) 
P 
hosphorylation and dephosphorylation of Ser, 
Thr, and Tyr residues have a critical role in 
modulating the activity of a large number of 
regulatory proteins [l&3]. The addition of phosphate 
from a nucleoside triphosphate donor is catalyzed by a 
class of phosphotransferase enzymes known as protein 
kinases. Enzymes collectively referred to as protein 
phophatases catalyze the removal of specific phos- 
phate groups. Evidence accumulated over the past 
decade has made it clear that these enzymes and their 
substrates form a complex, interconnected web that 
control most aspects of cell growth regulation 131. 
Two major classes of protein kinases exist: phospho 
transferases, with specificity toward the alcohol group 
of Ser and Thr, and those that transfer phosphate to 
Tyr [l-3]. Over 100 protein kinases have been identi- 
fied, and, for many of these enzymes, the consensus 
sequences for recognition and protein phosphorylation 
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have been identified [4,5]. These recognition paradigms 
consist of short linear sequences of amino acids sur- 
rounding the acceptor residue that have been identi- 
fied by sequence analysis of the protein or peptide 
substrates for a particular kinase. However, in many 
cases the specificities of the phosphotransferase en- 
zymes have only been deduced from sequence homol- 
ogy to protein kinases with experimentally determined 
specificities [z]. Because secondary and tertiary struc- 
tural features of the substrate may often play signifi- 
cant roles in the recognition process, the presence of a 
consensus sequence is not sufficient evidence for phos- 
phorylation. As underscored by Kennelly and Krebs 
[4], “Consensus sequence information functions best as 
a guide whose implications must be confirmed or 
refuted experimentally.” 
Numerous experimental strategies for determining 
the sites of phosphorylation during Edman sequence 
analysis of peptides have been devised. Such methods 
usually involve detection of inorganic [32 PIphosphate 
(released into the wash or bound to the sample sup- 
port) in the sequencer cycles [6-91 or detection of 
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stable elimination products or derivatives such as S- 
ethylcysteine, which is formed from phosphoserine by 
elimination of the phosphate, followed by the addi- 
tion of ethanethiol [lo]. However, these methods are 
limited by the liability of the phosphoester bonds to 
Ser and Thr, the low recovery and high carryover of 
phosphotyrosine in the automated Edman chemistry, 
and the lack of specificity or incompleteness of reaction 
for derivatives [6-111. At present, the most reliable 
methods for determining the sequence and modifica- 
tion site of phosphopeptides utilize Edman degrada- 
tion in combination with tandem mass spectrometry 
(MS/MS) [ll-181. 
Before phosphorylation sites can be determined, 
phosphopeptides must be produced and isolated from 
the phosphoprotein. This is usually accomplished by 
radiolabeling the intact protein with [:‘*P]phosphate, 
cleaving it with a protease, such as trypsin, or chemi- 
cally with cyanogen bromide, and then isolating the 
radiolabeled peptides following chromatographic sepa- 
ration [6-S]. Where the protein sequence is known, the 
molecular weight of the putative phosphopeptide ob- 
tained by mass spectrometry or liquid chromatogra- 
phy/mass spectrometry (LC/MS) analysis can be used 
to independently corroborate the presence of phos- 
phate by the SO-Da difference between the observed 
mass of the peptide and that calculated based on the 
sequence [12,19-221. A novel electrospray (ES) LC/MS 
procedure has been developed by Covey et nl. [23] that 
employs neutral-loss scanning to identify phosphopep- 
tides in mixtures on the basis of their tendency to lose 
neutral phosphoric acid from the doubly charged pre- 
cursor (i.e., a loss of 98 Da/z = 98/Z = 49). Such losses 
are favored for phosphoserine and phosphothreonine, 
which can readily undergo p-elimination of the side 
chain I121. Unfortunately, different mass-to-charge ra- 
tio values must be monitored for the same neutral loss, 
depending on the charge states of the precursors: this 
can only be practically accomplished in separate 
LC/MS/MS experiments for each charge state [24]. 
Moreover, it is unlikely that phosphotyrosine will un- 
dergo a neutral loss of phosphoric acid because such a 
loss would require that a bond to the aromatic ring be 
broken. 
We developed a mass spectrometry-based strategy 
for selective identification of peptides containing phos- 
phate liked to Ser, Thr, and Tyr without the need for 
radiolabeling. The method involves the generation and 
detection of phosphate-specific fragment ions during 
negative ion LC/ESMS analysis of protein digests. The 
present work is an outgrowth of our earlier studies on 
methods for selective glycopeptide detection t24, 251. 
Once phosphopeptides have been identified, Edman 
degradation and ESMS/MS may be used to provide 
the sequence and location of the phosphorylated amino 
acid [ 16-181. Here we illustrate the selectivity and 
sensitivity of the approach using a mixture of peptides 
and phosphopeptides containing the three commonly 
phosphorylated amino acids. 
Experimental 
Phosphopeptides and their nonphosphorylated analogs 
(Table 1) were obtained from the Protein and Carbohy- 
drate Structure Facility, University of Michigan Medi- 
cal School (Ann Arbor, MI). Peptides 7-11 (Table 2) 
were obtained as a mixture (Peptide Retention Stan- 
dard, Sl-S5) from Pierce (Rockford, IL). All other 
peptides (Table 2) were obtained from Peninsula Labo- 
ratories (Belmont, CA) or Bachem Bioscience, Inc. 
(Philadelphia, PA). All peptides were used without 
further desalting or purification. Peptides were infused 
directly into the mass spectrometer at 200 pmol/pL in 
water/acetonitrile 68:32 (v/v) containing 0.08% tri- 
fluoroacetic acid (TFA) at a flow rate of 4 pL/min by 
means of a model 22 Harvard Apparatus Syringe pump 
(South Natick, MA). 
A mixture of 50 pmol of each of the six model 
compounds was used for the initial LC/ESMS analy- 
ses using packed capillary columns. Gradient high-per- 
formance liquid chromatography (HPLC) was carried 
out using an Applied Biosystems 1408 Microgradient 
system (Foster City, CA) with dual syringe pumps, a 
250~PI, dynamic mixer, and a Rheodyne model 8125 
injector with a 2O-pL replaceable sample loop. The 
HPLC cohunn was an LC Packings (San Francisco, CA) 
Fusica capillary column (320 pm X 15 cm) custom 
packed with 5+m, 300-A pore size, C-18 packing from 
Vydac (The Separations Group, Hesperia, CA). Ab- 
sorbance was monitored at 215 nm using an Applied 
Biosystems model 785A programmable absorbance de- 
tector. The flow cell of the detector was replaced with 
an LC Packings U-Z View capillary flow cell with a 
35-nL internal volume and 8-mm path length. The flow 
of the mobile phase was reduced from approximately 
100 kL/min at the pump down to 4-5 pL/min lead- 
ing to the injector and column utilizing a solvent split 
at a low dead-volume Valco tee with a length of 
fused-silica restrictor on the waste leg. The capillary 
column fits directly into the injector, and a fused-silica 
extension tube connects the cohunn to the W detector. 
A second length of 50-pm i.d. fused silica leads from 
the UV detector and is threaded directly to the tip of 
the ion-spray needle. The mobile phases used for radi- 
ant elution consisted of (A) 0.1% (v/v) TFA and (9) 
acetonitrile/water 90:10 (v/v) containing 0.1% TFA. 
Table 1. Phosphorylated peptide models and their corresponding 
nonphosphorylatedanalogs 
Sequence Mra (monoisotopic) 
1 KRT(PO,H,)IRR 908.5 
2 KRTIRR 828.5 
3 KRPS(PO,H,)QRHGSKY 1422.7 
4 KRPSQRHGSKY 1342.7 
5 AC-RRLIEDAEY(P03H2kARG-NH, 1639.8 
6 AC-RRLIEDAEYAARG-NH, 1559.8 
aM,. relative molecular mass. 
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1 TYSK 497.2 
2 CGG 245.1 
3 KRT(PO,H,)IRR 908.5 
4 KRPS(PO,H,bQRHGSKY 1422.7 
5 KRTlRR 828.5 
6 KRPSQRHGSKY 1342.7 
7 RGAGGLGLGK-NH, 883.5 
8 Ac-RGGGGLGLGK-NH, 911.5 
9 AC-RGAGGLGLGK-NH, 925.5 
10 AC-RGVGGLGLGK-NH, 953.6 
11 AC-RGWGLGLGK-MH, 995.6 
12 ISRPPGFSPFR 1259.7 
13 MLF 409.2 
14 AC-RRLIEDAEY(PO,H,&ARG-NH, 1639.8 
15 AC-RRLIEDAEYAARG-NH, 1559.8 
16 DRVYIHPFHLLWS 1757.9 
The gradient conditions were as follows: 5% B (hold 5 
min) to 50% 3 linearly in 30 min; then linearly to 100% 
B in 5 min with no delays. Separations using 2.1-mm 
columns were carried out using a Beckman System 
Gold (San Ran-ton, CA) equipped with a model 126 
programmable solvent module and model 166 vari- 
able-wavelength detector with microflow cell. An AST- 
286 PC was used to control the system and to store 
and manipulate data via the System Gold software. 
The standard mixer on the 126 solvent module was 
replaced with a Lee Visco-Jet Micro-Mixer (Westbrook, 
CT) with a 250-PL internal volume. Reversed-phase- 
HPLC separation was done on a fully end-capped C-18 
column from Vydac (25-cm x 2.1~mm id. with 5-pm 
particles) with a Brownlee RI’-300 guard column (30 x 
2.1 mm id., 7-pm particle size) using linear gradient 
elution (as above) at 200 pL/min. A flow of 5 pLL/min 
from the column was diverted to the mass spectrome- 
ter, as described above. 
ES mass spectra were recorded on a Perkin-Elmer 
Sciex API-III triple quadrupole mass spectrometer 
(Thornhill, Ontario, Canada) fitted with an articulated, 
pneumatically assisted nebulization probe and an at- 
mospheric pressure ionization source. The tuning and 
calibration solution consisted of a mixture of 
polypropylene glycol (PPG) 424, 1000, and 2000 (3 x 
10d5 M, 1 X 10L4 M, and 2 x 10L4 M, respectively) in 
50:50;0.1 water/methanol/formic acid (v/v/v>, 1 mM 
NH,OAc. The range m/z lo-2400 was calibrated in 
the negative ion mode by multiple-ion monitoring of 
the isotope clusters of five PPC ion signals and the 
TFA anion (m/z 1131. Mass-to-charge ratio assign 
ments in the figures are the measured peak tops and 
are closer either to the monoisotopic or to the average 
mass-to-charge ratio, depending on the charge state 
and the isotopic distribution. ES and LC/ES mass 
spectra were recorded at instrument conditions suffi- 
cient to resolve the isomers of the PPG/HCO; singly 
charged anion at m/z 992 (55% valley definition). The 
ion-spray needle voltage was operated at -3.7 kV, 
with the interface plate at -700 V. The nebulization 
gas consisted of compressed air purified by a Balston 
75-85 Zero Grade Air Generator (Lexington, MA) at 
35540 psi flowing at 0.8 L/mm. A curtain of bottled 
nitrogen as (99.999%) was used at a flow rate of 0.8 
L/min. Our experience shows Ql transmitting low- 
mass ions more efficiently than Q3 in conventional 
scan modes, so we used Ql exclusively in these experi- 
ments. 
For infusions of single compounds, Ql was scanned 
over a range of m/z 50-1800 at 6 s/scan in 0.25-m/z 
steps; mass spectra were recorded at orifice (OR) po 
tentials of - 65, - 115, or - 350 V. The observation that 
the intensity of the low-mass, phosphopeptide marker 
ions was still increasing at the highest allowable OR 
setting of -250 V suggested the need for even higher 
OR voltages. Furthermore, because we wished to be 
able to step the OR voltage during the scan, it was 
necessary that the OR power suppIy be under com- 
puter control. By disconnecting the &&dard OR power 
supply and connecting the computer-controlled inter- 
face power supply to the OR and an external power 
supply (Bertan, Hicksville, NY) to the interface plate, 
we were able to achieve OR values of i7OO V. 
During LC-ESMS using single-ion monitoring (SIM), 
the Ql mass analyzer was scanned to monitor m/z 
62.87-63.12, m/z 78.87-79.12, and m/z 96.87-97.12 
using 0.05-m/2 steps, a dwell time of 330 ms/step, 
and a total scan time of 0.57 s. For a related SIM 
experiment, the Ql mass analyzer was set to monitor 
only the peak tops (m/z 63.0, 79.0, and 97.0) with a 
dwell time of 125 ms and a total scan time of 0.56 s 
(data not shown). The OR voltage was set to -350 V 
for both SIM experiments, and no significant differ- 
ences were observed between the two approaches. 
For full-scan LC/ESMS, the quadrupole was 
scanned discontinuosly over the ranges m/z 59-99 
and m/z 400-2000 in 0.25-m/z steps and a total scan 
time of 6 s. The OR voltage was set to - 350 V during 
acquisition of the range m/z 59-99 and then stepped 
to - 115 V and held constant from nr/z 400 to 2000 
(see, later, dotted line in Figure 4a). 
Results and Discussion 
An objective of this study was to identify marker ions 
that could be used to locate phosphopeptide-contain 
ing fractions during LC-ESMS of an enzymatically di- 
gested, phosphorylated protein. Using such a method, 
fractions identified as phosphopeptide containing could 
then be collected and further analyzed by other tech- 
niques (e.g., positive ion mass spectrometry, MS/MS, 
amino acid analysis, Edman degradation) to corrobo 
rate the presence of phosphate and to identify the 
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precise phosphorylation site(s). To accomplish this we 
studied three phosphopeptide models (Table l), each 
of which contained either Ser-, Thr-, or Tyr-linked 
phosphate, and three homologous peptides lacking 
phosphate, which acted as model controls. 
Positive and negative ion ES mass spectra of the 
phosphopeptides were recorded over a wide range of 
OR potentials (from 65 to 250 V in positive ion; from 
-65 to -250 V in negative ion). On the Sciex 
quadrupole mass spectrometer, the OR voltage is the 
source declustering potential, and this voltage is also 
used to control the degree of collision-induced dissoci- 
ation (CID) occurring in the high-pressure region be- 
tween the OR and Ql. No characteristic low mass- 
to-charge ratio fragment ions were observed in the 
positive ion data for the phosphopeptides over the 
range of OR values studied (date now shown), how- 
ever, fragments formed by loss of H,PO, from 
the pseudomolecular ions could be observed for the 
peptides phosphorylated on Ser or Thr in both the 
negative and positive ion spectra. The loss of phospho- 
ric acid was more pronounced in the positive ion data 
and appeared at lower collisional excitation potentials 
than in the negative ion data. Interestingly, strong 
losses of 17 Da (NH,), 18 Da tH,O), 80 Da (HPO,), 
and 98 Da (HJ’OJ were observed at relatively high 
a OR=85 
b OR=115 
Figure 1. Effect of orifice (OR) voltage on negative ion ES mass spectra of the phosphoserine- 
containing peptide (KRE@O,H,JQRHGSKY). SUI-II of five SC~IW; 400 pmol mmmed. The region 
m/z 50-100 shown in the expansion on the left is on the same vertical scale as the full spectrum 
illustrated on the right. Rel. Ink, relative intensity. 
OR values in both the positive and negative ion data 
for the phosphotyrosine-containing model peptide 
(compound 5, Table 1). The product ion spectrum of 
the [M + 2H]*’ of this peptide in positive ion also 
exhibited intense ions corresponding to the same four 
losses (data not shown), however, it is most likely that 
the 9%Da loss is due to the combined loss of H,O 
(from a residue other than phosphotyrosine) and HPO,, 
rather than the direct loss of HJ’O, from phosphoty- 
rosine. This conclusion is consistent with literature 
reports on the mass spectrometry and MS/MS of phos- 
photyrosine-containing peptides t12, 16, 181. The ap- 
parent absence of phosphoric acid loss from phosphe 
tyrosine (with the exception of nominally equivalent 
losses, as noted above) and the fact that the charge 
state of the parent ion must be known in advance limit 
the utility of neutral loss scanning as a general method 
for phosphopeptide detection (or glycopeptide detec- 
tion; see ref. 24) in LC/ESMS. Furthermore, the biolog- 
ical importance of Tyr phosphorylation militates for a 
more universal method of detection. 
At sufficiently high absolute OR potentials (collision 
energies), the negative ion ES mass spectra for all three 
varieties of phosphate linkage showed two unique 
phosphopeptide fragment ions: m/z 79 (PO;) and 
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(H,PO<) can derive from two of the phosphorylated 
peptides, the observation of m/z 97 is not diagnostic 
for phosphorylated peptides because anions of this 
mass-tocharge ratio can derive from other sources, 
such as sulfated peptides or TFA (C,F,O-). Indeed, a 
reconstructed ion trace for m/z 97 in the LC-ESMS 
data resulted in marked signal intensity increases 
(chromatographic peaks) during elution of phosphory- 
lated and nonphosphorylated peptides alike, presum- 
ably due to CID of the abundant [M + TFA,,]- adduct 
species (see below). Our strategy was to convert, by 
means of higher in-source collision energies, any phos- 
phate-derived signal at m/z 97, which is nonspecific, 
into m/z 79 (PO;) and m/z 63 (PO;), which are 
highly specific. The diagnostic value of m/z 79 for 
phosphopeptide detection was substantiated in the case 
of the phosphotyrosine peptide by acquiring a CID 
product ion spectrum of the [M - 2H12- ion at m/z 
813.2 using a collision cell (42) with argon target gas 
(data not shown). Thus, the high specificity of the two 
marker ions makes in-source CID, negative ion 
LC/ESMS a useful and universal method for locating 
phosphopeptide-containing peaks during HPLC sepa- 
ration. 
Negative ion ESMS was optimized for detection of 
the phosphopeptide-specific marker ions using the 
phosphoserine-containing peptide, which gave the 
weakest response of the three types of phosphorylated 
peptides. At OR values ranging from -65 to - 115 V 
(Figure la and b), we observed [M - HI-, [M - H + 
TFA]-, and IM - 2H + (TFA)J- ions, where n = 
1-8, depending on the voltage and the peptide compo- 
sition. TFA adducts to the molecular ion were greatly 
diminished at -115 V compared with the standard 
-65-V setting. Minimization of adducts simplifies the 
spectral data, facilitates molecular weight measure- 
ments when dealing with mixtures, and improves the 
intensity of individual signals (e.g., compare the [M - 
HI- appearing at m/z 1422 in Figure la and b). On 
the other hand, the spacing between the TFA adducts 
can be used to determine the charge state if a molecu- 
lar weight-related ion; observation of peaks 57 m/t 
apart implies doubly charged ions (114/2 = 57) (see 
Figure la). In TFA-containing mobile phases the marker 
ions appearing at m/z 63.0 and 79.0 maximized at OR 
settings of approximately -3.50 V (which is 100 V 
beyond the *250-V range of the standard power sup- 
ply for the instrument; see Experimental for details of 
the conversion of the power supply setups). The abun- 
dance of m/z 63.0 increased approximately tenfold 
and that of m/z 79.0 approximately twofold by in- 
creasing the OR voltage from - 250 to - 350 V. TFA- 
derived fragment ions at m/z 69 (CF;) and 97 
(C,F,O-) were observed at all OR values. At higher 
OR voltages (greater than - 200 V), significant [M - H 
- H,PO,]- or [M - H - H,O - HPOJ fragment 
ions and peptide backbone fragment ions were also 
observed for the three model phosphopeptides (e.g., 
see Figure lc). In non-TFA-containing mobile phases 
(e.g., aqueous/organic mixtures containing 0.2% 
formic acid or 0.2% NH,), m/z 63 and 79 were ob- 
served to maximize at an OR voltage of approximately 
-200 V. This suggests that postcolumn addition of 
modifiers such as formic acid may permit lower OR 
settings to be employed during negative ion LC/ESMS 
for marker ion generation with high sensitivity. 
The optimized orifice setting of -350 V was then 
applied to the LC/ESMS analysis of a mixture of the 
six model peptides shown in Table 1 using simultane- 
ous UV detection and SIM. All six standards can be 
seen in the UV trace (Figure 2a), whereas the three 
phosphopeptides were selectively detected by the 
summed ion traces for the phosphate marker ions m/z 
63 and 79 (Figure 2b). The obvious benefits of the SIM 
approach to LC/ESMS analyses include highly specific 
detection of phosphopeptides, much enhanced signal- 
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Figure 2. Comparison of the simulta- 
neausly acquired (a) UV (215 mn) and 
(b) negative ion single-ion monitoring 
(SIM) mass (m/z 63 spectrometry and 
79) traces from an LC separation of a 
mixh~re of 50 pm01 of each of the six 
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to-noise ratio, and consequent lower limit of detection, 
and improved chromatographic peak definition, which 
results from faster data acquisition (e.g., 0.5 s/scan). 
The disadvantage of the technique is the absence of 
any molecular weight information; further analysis of 
the collected fractions of LC/ESMS in a full-scan mode 
is necessary to obtain molecular weights. 
We also investigated techniques for selective detec- 
tion of phosphorylated peptides that preserved molec- 
ular weight information in the LC/ESMS data. The OR 
voltage setting, which controls the CID potential, must 
be adjusted so as to maximize within each spectrum 
the characteristic fragment ion signals and to minimize 
parent ion fragmentation. These contradictory require- 
ments are met by scanning or stepping the OR voltage 
during full-scan acquisition in a manner analogous to 
that previously described for selective detection of 
glycopeptides in LC/ESMS [24, 251. We have previ- 
ously referred to this technique of stepping or ramping 
the CID potential as collisional excitation scanning 
(24). The OR setting of - 115 V, which is sufficient to 
effectively reduce TFA adducted to the parent ions, 
and the -350-V OR setting, used for generation of 
phosphopeptide marker ions, were combined into a 
single scan by computer-controlled stepping of the OR 
voltage (see Experimental). Because the TFA-contain- 
ing mobile phase produces significant background ions 
even at an orifice setting of -350 V (Figure lc), the 
mass-to-charge ratio range between m/z 100 and 400 
was omitted from the full-scan mode LC/ESMS acqui- 
sition. The resulting spectra would contain diagnostic 
fragments, if present, in the low mass-to-charge ratio 
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tides, phosphorylated or not, in the higher mass-to- 
charge ratio region. 
We applied this full-scan, stepped collision energy 
method to the same mixture of peptides as was used 
for the SIM experiments (Table 1). The resulting total 
ion chromatogram (TIC) (Figure 3a) is qualitatively 
similar to the UV trace in Figure 2a. As expected, these 
traces do not correspond quantitatively because the 
UV detector and mass spectrometer are responding to 
different characteristics of the peptides [26]. Although 
both the UV and TIC traces provide relatively nonspe- 
cific detection of peptides and phosphopeptides, the 
reconstructed ion chromatogram for m/z 79 (Figure 
3b) was nearly identical to the summed ion trace of 
m/z 63 and 79 from the SIM experiment (Figure 2b), 
and both were specific for phosphopeptides. The 
molecular weights-of the six peptizes (Table 1) were 
indicated by significant, singly charged, deprotonated 
molecular ions together with their less intense TFA-ad- 
duct satellite peaks (see Figure 4 for the three spectra 
of the three phosphopeptides). We also observed dou- 
bly charged molecular ions in the form of a series of 
TFA adducts with the [M - 2H]‘- not always present. 
Although the phosphoserine peptide gave the poorest 
response, it was clearly identified as a phosphorylated 
peptide, and the molecular weight was determined in 
the LC/MS data at the 50-pmol level. Additional im- 
provements in the sensitivity for detection of the phos- 
phopeptide marker ions during full-scan acquisition 
could be gamed by using variants of the scan method 
described. For example, a scan in which m/z 63 and 
79 are selectively monitored at high OR for long dwell 
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Figure 3. Negative ion, stepped collisional excitation, scanning LC/ES mass spectra using the same 
peptide mixhme as in Figure 2. (a) Total ion chromatogram (TIC); (b) reconstructed-ion chro- 
matogram WC) for m/z 79 (PO, ). 
716 HUDDLESTON ET AL. J Am Sot Mass Spectmm 1993,4,710-717 
0 k 
(M - ‘(; ;;F*d*- K R P S Q R H G S K Y 
82Z.8 
(3) (M - H) 
25 h;Ls 
B81.5 1421.8 





100 AC-R R L I E D A E Y A A R G -NH2 




(M - 2H)*- 
-: ElQ.O+TFA I--- 
%iYl'- 
0 .” ...,..l,. ‘.+ . 1250 1500 1750 
m/z 
Figure 4. Negative ion ES mass spectra for the three phosphopeptidesfrom the scanning LC/ESMS 
experiment shown in Figure 3. The break in the x axis between m/z 99 and 400 indicates the scan 
discontinuitv (see Exuerimental for details). (a) Peak 1; (b) ueak 3; W peak 5. OR, orifice voltage; Rel. 






Figure 5. Negative ion, stepped collisonal excitation, scanning LC/ES mass spectra of the peptide 
mixture shown in Table 2. TIC, total ion chromatogram; RX, reconstructed ion chromatogram for 
m/z 63 (PO,) and 79 (PO, 1; phosphopeptides are denoted by *. 
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each spectrum (3-5 s) would improve sensitivity with- 
out significantly lengthening the duration of each scan. 
This scan method is presently not supported by the 
software on the Sciex API-III. 
The potential utility of the stepped collision energy 
method for selective detection of phosphopeptides in 
complex mixtures is illustrated in Figure 5 for a mix- 
ture of 16 peptides (Table 21, only three of which are 
phophorylated. No false positives were detected; only 
the phosphopeptides produced response at m/z 63 
and 79. The peptides in this more complex mixture 
contain 17 of the 20 commonly occurring amino acids; 
only Asn, Sys, and Trp are not represented. However, 
in other studies, peptides containing Asn and Trp also 
did not give rise to false positives (Annan and Carr, 
unpublished observations). Peptides containing Cys 
(and alkylated forms thereof) have not yet been 
studied. 
The techniques investigated in this report make it 
possible to selectively detect phosphopeptides in a 
mixture. Sensitivity was carefully evaluated, although 
the spectral quality indicates that we are not at the 
sensitivity limit for either full-scan or SlM detection. 
On the basis of the observed ion count rates, we 
estimate that it should be possible to obtain useful 
data at the 1-5-pmol level in the SIM-LC/MS mode. 
The relative response of phosphorylated and nonphos- 
phorylated peptides in the full-scan negative ion mode 
has not yet been studied in detail, however, within 
each pair of peptides, the relative responses of the 
molecular weight-related ions for equimolar amounts 
of the phosphorylated versus the nonphosphorylated 
forms were within a factor of 3. Further studies will be 
required to determine whether the selected ion current 
traces for the molecular weight-related ions can be 
used to provide a rough estimate of the extent of 
phosphorylation at a given site. More quantitative esti- 
mates may be obtained from the UV trace, in instances 
where the phosphorylated and nonphoshorylated pep- 
tide peaks are well resolved, or by N-terminal se- 
quencing of the peptides in isolated fractions. Work is 
now in progress to use negative ion LC/ESMS with 
collision energy scanning to identify phosphopeptides 
from enzymatically digested phosphorylated proteins. 
We anticipate that negative ion LC/ESMS will provide 
useful, complementary data to those normally ob- 
tained in the positive-ion mode for protein digests, and 
that together these data sets could be used to improve 
the overall mapping of the sequence. 
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